Citation, commencement and interpretation
1.—(1) These Regulations may be cited as the Nicotine Inhaling Products (Age of Sale and Proxy Purchasing) Regulations 2015.
(2) Regulations 1 and 2 come into force on the day after the day on which these Regulations are made.
(3) Regulations 3 to 7 come into force on 1st October 2015.
(4) In these Regulations—
“marketing authorisation” has the meaning given by regulation 8(1) of the Human Medicines Regulations 2012(1);
“medical device” has the meaning given by regulation 2(1) of the Medical Devices Regulations 2002(2);
“medicinal product” has the meaning given by regulation 2(1) of the Human Medicines Regulations 2012;
“nicotine cartridge” means a cartridge which—
contains a substance which is not tobacco but consists of, or contains, nicotine(3), and
is intended to form part of a nicotine inhaling device;
“nicotine inhaling device” means a device which—
is intended to enable nicotine to be inhaled through a mouth piece (regardless of whether the device is also intended to enable any other substance to be inhaled through a mouth piece), but
is not tobacco, cigarette papers or a device intended to be used for the consumption of lit tobacco;
“nicotine inhaling product” means a nicotine inhaling device, nicotine cartridge or nicotine refill substance;
“nicotine refill substance” means a substance which—
is not tobacco but consists of, or contains, nicotine, and
is intended to be used to refill a nicotine inhaling device;
“parallel import licence” has the meaning given by regulation 48(2) of the Human Medicines Regulations 2012;
“prescription only medicine” has the meaning given by regulation 8(1) of the Human Medicines Regulations 2012.
S.I. 2012/1916. .Relevant amendments were made by S.I. 2013/235, 1855, 2593, 2014/490, 1878.
S.I. 2002/618. Relevant amendments were made by S.I 2008/2936.
See the definition of “tobacco” at section 92(12) of the Children and Families Act 2014.